Factors Influencing Cardiac Rehabilitation Success

NCT ID: NCT07328789

Last Updated: 2026-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-03

Study Completion Date

2029-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cardiovascular diseases, especially after life-saving surgeries, require comprehensive cardiac rehabilitation (CR). We know that the effectiveness of CR varies among patients. The main goal of this study is to understand which factors-psychological, physical, cognitive, biochemical, and hormonal-influence the success and long-term durability of the recovery process. These findings will help us create more effective and personalized treatment programs.

Who is Being Studied and What is Being Assessed? Study Group: 150 patients of both sexes, aged 50-80 years, hospitalized in the cardiac rehabilitation ward, primarily after Coronary Artery Bypass Grafting (CABG).

Study Period: Patients will be assessed at the start of their hospital stay, at the end of rehabilitation, and again 3-6 months after discharge.

Key Assessment Areas (Modulating Factors)

Physical Status and Fitness:

Exercise tolerance (6-Minute Walk Test).

Muscle strength (handgrip), balance, and gait.

Body composition (analysis of muscle mass and fat tissue).

Respiratory function and diaphragm mobility (ultrasound).

Psychological and Cognitive Factors:

Assessment of anxiety, depression, and general mental well-being.

Evaluation of cognitive functions (memory, concentration) following cardiac surgery.

Sleep Problems (OSA):

Assessment of the risk and severity of Obstructive Sleep Apnea (OSA), which is common in cardiac patients.

Analysis of OSA risk factors related to oral health (dentition, microbiome) and craniofacial structure.

Biological Markers:

Hormonal tests (e.g., testosterone, estradiol) and their correlation with psycho-physical condition and the rehabilitation process.

Analysis of metabolic and muscle-related biomarkers (e.g., myokines: irisin, myostatin).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cardiovascular diseases, particularly advanced coronary artery disease requiring interventions like Coronary Artery Bypass Grafting (CABG), are major global health concerns. Comprehensive cardiac rehabilitation (CR) is a crucial element in patient recovery, yet its effectiveness varies significantly. The main objective of this project is the comprehensive evaluation of the actual effectiveness of standard CR and the identification of multi-faceted factors-biological, functional, and psychosocial-that influence its outcomes and long-term prognosis.

Methodology and Study Design The project plans to recruit 150 male and female patients, aged 50-80 years, who are hospitalized in the cardiac rehabilitation ward, primarily following CABG surgery.

Assessments will be conducted at three key time points to monitor the dynamic nature of changes:

Baseline (T0): At the beginning of cardiac rehabilitation.

Post-Rehab (T1): At the conclusion of the standard rehabilitation program.

Follow-up (T2): Approximately 3-6 months after the patient's discharge.

Detailed Research Domains

The study will focus on several key domains to comprehensively assess the mechanisms underlying recovery:

A. Functional and Physical Assessment

Exercise Tolerance: Measured using the 6-Minute Walk Test (6MWT).

Physical Fitness and Strength: Assessed via Handgrip Dynamometry, the Barthel Scale for daily living activities, and the Tinetti Scale for balance and gait.

Body Composition: Detailed analysis using Bioelectrical Impedance Analysis (BIA) to track changes in muscle mass and fat tissue.

Diaphragm Function: Evaluation of diaphragm muscle thickness and mobility using Ultrasound (USG) to monitor respiratory improvement.

Postural Stability: Assessment of pressure distribution using a tensiometric mat (posturography).

B. Psychological and Neurocognitive Assessment

Mental Status: Evaluated using validated scales, including the WHO-5 Well-Being Index and the HADS Scale for anxiety and depression.

Cognitive Function: Screening for potential post-surgery cognitive impairment (memory, concentration) using the MoCA and MMSE scales.

C. Sleep Disorders and Biological/Hormonal Factors

Obstructive Sleep Apnea (OSA): Objective assessment of the frequency and severity of OSA using a portable sleep monitor.

Oral Health \& OSA Risk: Detailed dental and craniofacial examinations to assess OSA risk factors related to the oral cavity status.

Hormonal and Biochemical Markers: Analysis of sex hormones (Testosterone, Estradiol) and their correlation with overall condition and rehabilitation response.

Myokines and Metabolic Signaling: Measurement of myokines (Irisin, Myostatin) and related proteins to understand mechanisms of exercise adaptation.

Standard Laboratory Tests: Including standard markers like lipid profile, glucose, HbA1c, CRP, homocysteine, and Vitamin D3.

Significance and Expected Outcomes The project aims to establish a patient profile that clearly identifies who benefits most from CR and who is at risk of poor outcomes. This identification of predictive factors will enable the early introduction of personalized interventions, such as targeted physical therapy, psychological support, or specialized diagnostics for sleep disorders. The ultimate goal is to optimize CR programs, maximizing gains in physical capacity, quality of life, and the long-term cardiac prognosis for patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rehabilitation effective

This study is an observational, non-pharmacological, multi-domain assessment of patients undergoing standard comprehensive cardiac rehabilitation (CR) following CABG surgery. The intervention involves a detailed, longitudinal, three-stage evaluation (Baseline, Post-Rehab, 3-6 Month Follow-up) of the factors influencing CR outcomes.

The CR itself is a standard hospital-based program, but the research intervention is distinguished by its holistic focus on measuring and correlating:

Objective Functional Data: Exercise capacity (6MWT), muscle strength, diaphragm function (USG), and postural stability.

Multifactorial Co-morbidities: Screening for Obstructive Sleep Apnea (OSA) (NOX-T3), Cognitive Dysfunction (MoCA/MMSE), and the role of oral health in OSA risk.

Biological \& Hormonal Profile: Measuring Sex Hormones (Testosterone, Estradiol) and Myokines (Irisin, Myostatin) to understand personalized metabolic and adaptive responses to the rehabilitation program.

The intervention aims to

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male patients aged 50-80 years
* Hospitalization in the Cardiac Rehabilitation Ward
* Undergone coronary artery bypass graft (CABG) surgery within the last 30 days
* Written, informed consent to participate in the study

Exclusion Criteria

* Type II diabetes treated with insulin
* Neuro-surgical operation in the last 6 months
* Aneurysms of the cerebral arteries and aorta
* Recurrent ischemic stroke (Cerebral Vascular Accident)
* Presence of a pacemaker
* Current treatment with testosterone
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pomeranian Medical University Szczecin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aleksandra Rył

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KB-006/65/2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.